Company performance
Add to research
Current Price
as of Jun 20, 2025$12.29
P/E Ratio
N/A
Market Cap
$333.31M
Description
Add to research
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerARCT
- Price$12.29-0.49%
Trading Information
- Market cap$333.31M
- Float91.56%
- Average Daily Volume (1m)482,976
- Average Daily Volume (3m)447,619
- EPS-$2.52
Company
- Revenue$131.27M
- Rev growth (1yr)-21.84%
- Net income-$14.08M
- Gross margin96.86%
- EBITDA margin-55.43%
- EBITDA-$14.12M
- EV$74.27M
- EV/Revenue0.57
- P/EN/A
- P/S2.54
- P/B1.43
- Debt/Equity18.25
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset